pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3650 |
Genomic Coordinates | chr5: 38557502 - 38557561 |
Description | Homo sapiens miR-3650 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-3650 |
Sequence | 4| AGGUGUGUCUGUAGAGUCC |22 |
Evidence | Experimental |
Experiments | 454 |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KIF13A | ||||||||||||||||||||
Synonyms | RBKIN, bA500C11.2 | ||||||||||||||||||||
Description | kinesin family member 13A | ||||||||||||||||||||
Transcript | NM_001105568 | ||||||||||||||||||||
Other Transcripts | NM_001105567 , NM_001105566 , NM_022113 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KIF13A | |||||||||||||||||||||
3'UTR of KIF13A (miRNA target sites are highlighted) |
>KIF13A|NM_001105568|3'UTR 1 GAGCAGCAAGCACCCCTCCTCAGGCCACAGCTTGGCGTCTTTGTTCGCCTGGTCACCTTGGGCAAGCACCAGCCCCATCT 81 CTAAAACATGCTGCCGCCTGGCTGGACCTCAGACCAGAAGCTGGAGAATCCACACCGTGCACTTCCTGGGCCACCTCCTT 161 TCCCCTCCCCAGTGGGAGAAGCGGCACTTTGTCACTTGGGTGAATCAACAGCCTCTGCTTTTTCCAGAAAGCAAGAGAAC 241 TGAAAATCCTGGATTAACTAAGTGACAGTATTTTTTTTTGCACTTACTACACACCTCCACTGTATAGAAACCTCTACAGA 321 TTCCAACAGACTTTATTCTTGTACAATTTTAATCAGTTCTTACTGTAGAATCTGGAGTCAATGCTCTAATCTGTTTTTTA 401 TAAATAATATATATTATGTATATGAAATGTGTATCTATAGTATGTCTGGAGACAGACAAGGCTGCACACTAAAATGCAGA 481 TAAAGGTGATTTGTAGAAAATCATAAGGTACTGGACTTCGTTACAAAGCAACTTGGGCGATCTCTTATACATGAGCAGAT 561 GAAAAATATTTTATTGCCTAAGAATGAGCTTGCAAATCCCTCTTTGCAGAAAAGGTTATAGAATGCTGTTCTTTATAACC 641 AAAGAACTTACATAAGACAACATTTTTGCTGTCCACTCTTTTGTGTGAACATGTATGTTTGACTGCAAGTTTGGTGCCAT 721 AATTCCCTTGGCTACCAAGCCACGTGCTGCCATTCTCTGTCCTTTGTTTCATAAGCACACTGAGAAATCTCACAGCTATA 801 TTCTTTGGTCTTCCACCTGCCCCTCCACCTGCTGACTTGACATTGTATTATAACTGTTGACAATGACTGGGGTCCTGACT 881 CCACAGTTGCCTGGACCGTGGCTCAGCCCAGCTGGGCAGGTGGAATGAAGAGAGCCGTATTACTGTAAGAAAACACAAGG 961 ACAGCCAGGAGTAGTGGTGGGGTGGGTGGGGTGGGAGGTGTTGATTTTTGTGTGTTTCTGTGTGTGTGGTTTTGTTTTGG 1041 ATTGGTAGGTTTCACTGTGGCGTGGTTTTGCTGTTGTTATTTTGCTTGATTCTGGAAAATGCTGAGGAGATGGACTGAGC 1121 TATGAAGTTCAATGGTTCACCCTTTACCATGTTTGCAGGAGATGATCGAATACAGATGACCCTGCTGTCGTGTCTTCATT 1201 TGTAAAATTCTCCTACAAATGGAGACATTGAAGGATTATGTGTATGGAAATTTTTACAAAATTCCTTTCTGTACCTATTC 1281 TGTAGATGCCTGTATAATCGGTCTGGATGTACAGCTATAAATGTGTTGTGAGAGCAAGAGAGAGAGAATGGGTAGAGCCT 1361 GCTGTACCTTTTTTCTTTTAAATTCTTCGAGTTGGTAAATGAGTAAGATATTGGAAACCTTAATGAAAAGCTGCTGTTCA 1441 TGATTTGTGTGTATAGTGAGCTGACTGTAGTATTTTACTATTGTCTGTTAAAAAAAGAAAAACTGTAATTTATATCCCCT 1521 TTGAACTTTATTGTGTTTAATTGGTACACATTTCTGTGTGTGTGTGTGTGTATGTGTTTTAGAATACAAACTGTGTAATT 1601 CAGATTTTAAAACACTAATCATTTGTCTTTAATAACCCTGCCTTTAGTTTCAAATCTAACTTACCATATTTCTAAAAAAA 1681 AAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 63971.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000378814.5 | 3UTR | UAUUUUUUUUUGCACUUACUACACACCUCCACUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000378814.5 | 3UTR | AUUUUUUUUUGCACUUACUACACACCUCCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000378814.5 | 3UTR | UAUUUUUUUUUGCACUUACUACACACCUCCACUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000378814.5 | 3UTR | UAUUUUUUUUUGCACUUACUACACACCUCCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
121 hsa-miR-3650 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT075340 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT302326 | ACP1 | acid phosphatase 1, soluble | 2 | 2 | ||||||||
MIRT395212 | PRKCB | protein kinase C beta | 2 | 2 | ||||||||
MIRT404446 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT449647 | CASS4 | Cas scaffolding protein family member 4 | 2 | 2 | ||||||||
MIRT451262 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 2 | ||||||||
MIRT452113 | IFITM1 | interferon induced transmembrane protein 1 | 2 | 2 | ||||||||
MIRT452723 | AGAP9 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 | 2 | 4 | ||||||||
MIRT452982 | CABP4 | calcium binding protein 4 | 2 | 2 | ||||||||
MIRT453966 | ATP13A4 | ATPase 13A4 | 2 | 6 | ||||||||
MIRT454112 | MRPL52 | mitochondrial ribosomal protein L52 | 2 | 2 | ||||||||
MIRT454343 | CDKL1 | cyclin dependent kinase like 1 | 2 | 2 | ||||||||
MIRT454405 | AKAP5 | A-kinase anchoring protein 5 | 2 | 2 | ||||||||
MIRT456224 | LIX1L | limb and CNS expressed 1 like | 2 | 4 | ||||||||
MIRT456232 | LHPP | phospholysine phosphohistidine inorganic pyrophosphate phosphatase | 2 | 6 | ||||||||
MIRT458505 | GSG2 | histone H3 associated protein kinase | 2 | 6 | ||||||||
MIRT461653 | G6PC | glucose-6-phosphatase catalytic subunit | 2 | 2 | ||||||||
MIRT461933 | TNFSF14 | TNF superfamily member 14 | 2 | 2 | ||||||||
MIRT462734 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT463817 | XKR4 | XK related 4 | 2 | 2 | ||||||||
MIRT463833 | WSB1 | WD repeat and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT464928 | TXLNA | taxilin alpha | 2 | 2 | ||||||||
MIRT465874 | TMEM43 | transmembrane protein 43 | 2 | 4 | ||||||||
MIRT467753 | SLC35F1 | solute carrier family 35 member F1 | 2 | 4 | ||||||||
MIRT468688 | SEC22C | SEC22 homolog C, vesicle trafficking protein | 2 | 4 | ||||||||
MIRT469453 | REL | REL proto-oncogene, NF-kB subunit | 2 | 6 | ||||||||
MIRT471931 | NRAS | NRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT474715 | KIF13A | kinesin family member 13A | 2 | 6 | ||||||||
MIRT475396 | ICMT | isoprenylcysteine carboxyl methyltransferase | 2 | 2 | ||||||||
MIRT475681 | HHIPL1 | HHIP like 1 | 2 | 2 | ||||||||
MIRT477016 | FAM217B | family with sequence similarity 217 member B | 2 | 2 | ||||||||
MIRT477073 | FAM208A | family with sequence similarity 208 member A | 2 | 4 | ||||||||
MIRT478172 | DENND5B | DENN domain containing 5B | 2 | 2 | ||||||||
MIRT478995 | COLGALT1 | collagen beta(1-O)galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT479700 | CCNT1 | cyclin T1 | 2 | 2 | ||||||||
MIRT482784 | STIM1 | stromal interaction molecule 1 | 2 | 2 | ||||||||
MIRT488682 | RAD23B | RAD23 homolog B, nucleotide excision repair protein | 2 | 2 | ||||||||
MIRT493179 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT494243 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 2 | ||||||||
MIRT508775 | GSG1 | germ cell associated 1 | 2 | 2 | ||||||||
MIRT509555 | ACTG1 | actin gamma 1 | 2 | 4 | ||||||||
MIRT510305 | PDRG1 | p53 and DNA damage regulated 1 | 2 | 2 | ||||||||
MIRT510976 | PFN2 | profilin 2 | 2 | 6 | ||||||||
MIRT517860 | NCAPD2 | non-SMC condensin I complex subunit D2 | 2 | 4 | ||||||||
MIRT519451 | CSTF1 | cleavage stimulation factor subunit 1 | 2 | 2 | ||||||||
MIRT521340 | RPP14 | ribonuclease P/MRP subunit p14 | 2 | 2 | ||||||||
MIRT522478 | MIPOL1 | mirror-image polydactyly 1 | 2 | 4 | ||||||||
MIRT522584 | MAPK1IP1L | mitogen-activated protein kinase 1 interacting protein 1 like | 2 | 2 | ||||||||
MIRT525629 | NUP93 | nucleoporin 93 | 2 | 4 | ||||||||
MIRT529240 | PORCN | porcupine O-acyltransferase | 2 | 2 | ||||||||
MIRT529788 | AP4S1 | adaptor related protein complex 4 sigma 1 subunit | 2 | 2 | ||||||||
MIRT530567 | ABHD15 | abhydrolase domain containing 15 | 2 | 2 | ||||||||
MIRT535784 | MTRNR2L11 | MT-RNR2-like 11 | 2 | 6 | ||||||||
MIRT536819 | HMGA1 | high mobility group AT-hook 1 | 2 | 2 | ||||||||
MIRT541615 | C11orf31 | selenoprotein H | 2 | 2 | ||||||||
MIRT546188 | TPD52 | tumor protein D52 | 2 | 4 | ||||||||
MIRT546201 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT547466 | MBNL3 | muscleblind like splicing regulator 3 | 2 | 8 | ||||||||
MIRT550570 | SLC2A5 | solute carrier family 2 member 5 | 2 | 2 | ||||||||
MIRT550778 | DBT | dihydrolipoamide branched chain transacylase E2 | 2 | 4 | ||||||||
MIRT550987 | RBM38 | RNA binding motif protein 38 | 2 | 2 | ||||||||
MIRT554735 | RHOC | ras homolog family member C | 2 | 2 | ||||||||
MIRT555390 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | 2 | 2 | ||||||||
MIRT556871 | IVNS1ABP | influenza virus NS1A binding protein | 2 | 2 | ||||||||
MIRT557530 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | 2 | 2 | ||||||||
MIRT564850 | ZBED3 | zinc finger BED-type containing 3 | 2 | 2 | ||||||||
MIRT569426 | DCAF8 | DDB1 and CUL4 associated factor 8 | 2 | 2 | ||||||||
MIRT569479 | CTSE | cathepsin E | 2 | 2 | ||||||||
MIRT569653 | SLC23A1 | solute carrier family 23 member 1 | 2 | 2 | ||||||||
MIRT570089 | KANSL1L | KAT8 regulatory NSL complex subunit 1 like | 2 | 4 | ||||||||
MIRT574074 | RNF152 | ring finger protein 152 | 2 | 2 | ||||||||
MIRT575199 | Entpd4 | ectonucleoside triphosphate diphosphohydrolase 4 | 2 | 2 | ||||||||
MIRT606929 | CDK15 | cyclin dependent kinase 15 | 2 | 2 | ||||||||
MIRT606959 | BDH1 | 3-hydroxybutyrate dehydrogenase 1 | 2 | 6 | ||||||||
MIRT606968 | FAM117B | family with sequence similarity 117 member B | 2 | 2 | ||||||||
MIRT606975 | ONECUT3 | one cut homeobox 3 | 2 | 2 | ||||||||
MIRT607002 | KCNQ5 | potassium voltage-gated channel subfamily Q member 5 | 2 | 2 | ||||||||
MIRT607129 | MARCH4 | membrane associated ring-CH-type finger 4 | 2 | 2 | ||||||||
MIRT607185 | SPRY4 | sprouty RTK signaling antagonist 4 | 2 | 4 | ||||||||
MIRT607547 | GLI2 | GLI family zinc finger 2 | 2 | 2 | ||||||||
MIRT607617 | TMEM130 | transmembrane protein 130 | 2 | 4 | ||||||||
MIRT607638 | FAM69C | family with sequence similarity 69 member C | 2 | 2 | ||||||||
MIRT607690 | MAPK10 | mitogen-activated protein kinase 10 | 2 | 2 | ||||||||
MIRT607810 | SPATA6 | spermatogenesis associated 6 | 2 | 2 | ||||||||
MIRT607945 | SSX2 | SSX family member 2 | 2 | 4 | ||||||||
MIRT608018 | CARNS1 | carnosine synthase 1 | 2 | 2 | ||||||||
MIRT608066 | SSX2B | SSX family member 2B | 2 | 4 | ||||||||
MIRT608833 | PTCHD1 | patched domain containing 1 | 2 | 4 | ||||||||
MIRT608857 | TCTE1 | t-complex-associated-testis-expressed 1 | 2 | 2 | ||||||||
MIRT608863 | BCAS1 | breast carcinoma amplified sequence 1 | 2 | 2 | ||||||||
MIRT608871 | NR2E1 | nuclear receptor subfamily 2 group E member 1 | 2 | 2 | ||||||||
MIRT608949 | CYP7B1 | cytochrome P450 family 7 subfamily B member 1 | 2 | 2 | ||||||||
MIRT608994 | PYGO1 | pygopus family PHD finger 1 | 2 | 2 | ||||||||
MIRT609060 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT609066 | IGLON5 | IgLON family member 5 | 2 | 4 | ||||||||
MIRT610789 | KLK2 | kallikrein related peptidase 2 | 2 | 2 | ||||||||
MIRT620567 | WBSCR27 | methyltransferase like 27 | 2 | 4 | ||||||||
MIRT624028 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT626738 | TXNL4B | thioredoxin like 4B | 2 | 2 | ||||||||
MIRT627162 | ZNF48 | zinc finger protein 48 | 2 | 2 | ||||||||
MIRT627198 | ZDHHC20 | zinc finger DHHC-type containing 20 | 2 | 2 | ||||||||
MIRT631188 | TSPAN14 | tetraspanin 14 | 2 | 2 | ||||||||
MIRT631967 | YIPF5 | Yip1 domain family member 5 | 2 | 2 | ||||||||
MIRT632888 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT636752 | SLC16A5 | solute carrier family 16 member 5 | 2 | 2 | ||||||||
MIRT637769 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT640735 | FAM83C | family with sequence similarity 83 member C | 2 | 2 | ||||||||
MIRT645611 | TSPAN6 | tetraspanin 6 | 2 | 2 | ||||||||
MIRT653679 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT654119 | RPS6KA5 | ribosomal protein S6 kinase A5 | 2 | 2 | ||||||||
MIRT655110 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT662230 | PGBD4 | piggyBac transposable element derived 4 | 2 | 2 | ||||||||
MIRT662332 | MYLK3 | myosin light chain kinase 3 | 2 | 2 | ||||||||
MIRT662730 | LRRC3C | leucine rich repeat containing 3C | 2 | 2 | ||||||||
MIRT668622 | EEA1 | early endosome antigen 1 | 2 | 2 | ||||||||
MIRT687702 | KRR1 | KRR1, small subunit processome component homolog | 2 | 2 | ||||||||
MIRT691171 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT701450 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT705501 | ASH1L | ASH1 like histone lysine methyltransferase | 2 | 2 | ||||||||
MIRT706893 | ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT707402 | KCNK12 | potassium two pore domain channel subfamily K member 12 | 2 | 2 |